Edition:
United States

People: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

3,474.85INR
25 Jul 2016
Change (% chg)

-- (--)
Prev Close
Rs3,474.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
31,110
52-wk High
Rs4,382.95
52-wk Low
Rs2,750.00

Chari, Raghav 

Dr. Raghav Chari is Executive Vice President- Proprietary of Dr. Reddy's Laboratories Ltd. He was SENIOR VICE-PRESIDENT- PROPRIETARY PRODUCTS of the company. He heads Proprietary Products segment and is responsible for developing a viable portfolio of products across Company's New Chemical Entities and Differentiated Formulations businesses. Dr. Chari joined the Company in 2006 as Vice President- Corporate Development for Company's New Chemical Entities and Specialty business and has helped shape Company's Proprietary Products business strategy while developing alliance platforms. He started his career with McKinsey and Company, where he spent several years as an Associate, Engagement Manager and finally Associate Principal in McKinsey’s Pharmaceuticals and Medical Products practice. After McKinsey, he took leadership roles in strategy and business development with several smaller biotech companies. Prior to joining the Company, he was the head of the Corporate Strategy function at NPS Pharmaceuticals. Dr. Chari is a graduate in Mathematics and Physics from the California Institute of Technology and holds a Ph.D in Theoretical Physics from Princeton University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Satish Reddy

114,639

G. Prasad

109,464,000

Saumen Chakraborty

15,000,000

Sripada Chandrasekhar

--

Abhijit Mukherjee

14,600,000

Amit Biswas

--
As Of  30 Mar 2014